Results 161 to 170 of about 38,393 (221)

Cardiovascular adverse effects of common non-oncologic medications: from mechanisms to clinical management. [PDF]

Eur Heart J Cardiovasc Pharmacother
Bahit MC, Agudo-Quilez P, Zamorano J, Gibson CM.   +3 more
europepmc   +1 more source

Overcoming the barriers to effective glycaemic control for type 2 diabetes [PDF]

, 2002
American Association of Clinical Endocrinologists., American Diabetes Association, Bailey CJ, Banerji MA, Banerji MA, Blonde L., Burkhard Göke, Charles A Reasner, Guidelines Subcommittee., Haupt E., Liebl A., Morris AD   +11 more
core   +1 more source

Diabetes Fact Sheet 2025: Comparative Epidemiology and Clinical Features of Obese and Non-Obese Diabetes in Korea. [PDF]

Diabetes Metab J
Kim JH, Kim B, Park SE, Ko SH, Choi SH, Cha BS, Han K, Lee SH.   +7 more
europepmc   +1 more source

Antidiabetic agents and male fertility: unraveling the impact of glucose-lowering therapies on sperm quality in diabetic males-a narrative review. [PDF]

Transl Androl Urol
Luo Z, Wang L, Luo J, Shi L, Wang L, Xie G.   +5 more
europepmc   +1 more source

Effects of sodium-glucose co-transporter-2 inhibitors on the risk of nephrolithiasis and urinary tract infections in Thai patients with type 2 diabetes: a hospital-based cohort study. [PDF]

Diabetol Metab Syndr
Lukkunaprasit T, Tansawet A, Siriyotha S, Looareesuwan P, Yang J, Kunakorntham P, Sirisreetreerux P, Anothaisintawee T, McKay GJ, Attia J, Thakkinstian A.   +10 more
europepmc   +1 more source

Hepatocyte ALOXE3 is induced during adaptive fasting and enhances insulin sensitivity by activating hepatic PPARγ [PDF]

, 2018
DeBosch, Brian J, Fujiwara, Hideji, Graham, Mark J, Higgins, Cassandra B, Mayer, Allyson L, Stothard, Alicyn I, Swarts, Benjamin M, Zhang, Yiming   +7 more
core   +1 more source

Repurposing Antidiabetic Medications for Parkinson's Disease: Focus on Biomarker Strategies for Disease Modification. [PDF]

Int J Mol Sci
Yelleswarapu NK, Sidiropoulos C.
europepmc   +1 more source

Effect of SGLT2 inhibitors on thiazolidinedione-induced changes in the volume status of patients with type 2 diabetes mellitus: a 6-month follow-up prospective study. [PDF]

Arch Endocrinol Metab
Unlusoy YB, Dizdar OS, Gunal Aİ.
europepmc   +1 more source

Lobeglitazone and the risk of renal progression in Korean patients with type 2 diabetes mellitus: a retrospective cohort study. [PDF]

BMJ Open
Hong SH, Lee H, Lee SY, Sung YA, Hong YS, Song DK, Jung H, Kim MH.   +7 more
europepmc   +1 more source